Page last updated: 2024-11-02

pioglitazone and Airway Remodeling

pioglitazone has been researched along with Airway Remodeling in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Airway Remodeling: The structural changes in the number, mass, size and/or composition of the airway tissues.

Research Excerpts

ExcerptRelevanceReference
"Peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone (PGZ) exhibits potential protective effects in asthma."3.88PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model. ( Deng, W; Fang, P; Liu, Y; Meng, X; Shi, H; Sun, X; Wang, G; Yang, S; Zhang, Y, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meng, X1
Sun, X1
Zhang, Y1
Shi, H1
Deng, W1
Liu, Y1
Wang, G1
Fang, P1
Yang, S1

Other Studies

1 other study available for pioglitazone and Airway Remodeling

ArticleYear
PPARγ Agonist PGZ Attenuates OVA-Induced Airway Inflammation and Airway Remodeling via RGS4 Signaling in Mouse Model.
    Inflammation, 2018, Volume: 41, Issue:6

    Topics: Airway Remodeling; Animals; Asthma; MAP Kinase Signaling System; Mice; Ovalbumin; Pioglitazone; PPAR

2018